Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1987 Dec;129(3):552–566.

Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

D Murphy 1, A Bishop 1, G Rindi 1, M N Murphy 1, G W Stamp 1, J Hanson 1, J M Polak 1, B Hogan 1
PMCID: PMC1899820  PMID: 2827490

Abstract

The authors have used transgenic mice to study the activity of a hybrid oncogene made up of 1.25 kb of 5' upstream sequences, derived from the bovine vasopressin gene, promoting the expression of the large T-antigen coding sequences of the early region of simian virus 40. Rather than promoting tumorigenesis in vasopressinergic cells of the hypothalamus, expression and activity of the hybrid oncogene, and consequent tumor formation, were confined to insulin-producing beta cells of the endocrine pancreas and to cells in the anterior pituitary. These observations suggest that the specificity of vasopressin gene expression normally results from an interaction between several regulatory elements, some of which are absent from the hybrid oncogene. The possible relationship between the endocrine tumor syndrome found in the vasopressin-SV40 transgenic mice and familial human multiple endocrine neoplasia is discussed.

Full text

PDF
552

Images in this article

559Figure 6
on p.559
556Figure 2
on p.556
556Figure 3
on p.556
558Figure 5
on p.558
560Figure 7
on p.560
561Figure 8
on p.561
561Figure 9
on p.561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams T. E., Alpert S., Hanahan D. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature. 1987 Jan 15;325(6101):223–228. doi: 10.1038/325223a0. [DOI] [PubMed] [Google Scholar]
  2. Betts J. B., O'Malley B. P., Rosenthal F. D. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature. Q J Med. 1980 Winter;49(193):69–76. [PubMed] [Google Scholar]
  3. Brandi M. L., Aurbach G. D., Fitzpatrick L. A., Quarto R., Spiegel A. M., Bliziotes M. M., Norton J. A., Doppman J. L., Marx S. J. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med. 1986 May 15;314(20):1287–1293. doi: 10.1056/NEJM198605153142004. [DOI] [PubMed] [Google Scholar]
  4. Brinster R. L., Chen H. Y., Messing A., van Dyke T., Levine A. J., Palmiter R. D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell. 1984 Jun;37(2):367–379. doi: 10.1016/0092-8674(84)90367-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burbach J. P., De Hoop M. J., Schmale H., Richter D., De Kloet E. R., Ten Haaf J. A., De Wied D. Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology. 1984 Dec;39(6):582–584. doi: 10.1159/000124040. [DOI] [PubMed] [Google Scholar]
  6. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  7. Gillies G. E., Linton E. A., Lowry P. J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 1982 Sep 23;299(5881):355–357. doi: 10.1038/299355a0. [DOI] [PubMed] [Google Scholar]
  8. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greene B. M., Golladay E. S., Mollitt D. L. Multiple endocrine adenopathy. Surg Gynecol Obstet. 1983 May;156(5):665–678. [PubMed] [Google Scholar]
  10. Hammer R. E., Krumlauf R., Camper S. A., Brinster R. L., Tilghman S. M. Diversity of alpha-fetoprotein gene expression in mice is generated by a combination of separate enhancer elements. Science. 1987 Jan 2;235(4784):53–58. doi: 10.1126/science.2432657. [DOI] [PubMed] [Google Scholar]
  11. Hammer R. E., Palmiter R. D., Brinster R. L. Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene. Nature. 1984 Sep 6;311(5981):65–67. doi: 10.1038/311065a0. [DOI] [PubMed] [Google Scholar]
  12. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 1985 May 9;315(6015):115–122. doi: 10.1038/315115a0. [DOI] [PubMed] [Google Scholar]
  13. Horn A. M., Robinson I. C., Fink G. Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal and Brattleboro rats. J Endocrinol. 1985 Feb;104(2):211–224. doi: 10.1677/joe.0.1040211. [DOI] [PubMed] [Google Scholar]
  14. Kaufman R. J., Sharp P. A. Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene. J Mol Biol. 1982 Aug 25;159(4):601–621. doi: 10.1016/0022-2836(82)90103-6. [DOI] [PubMed] [Google Scholar]
  15. Kollias G., Wrighton N., Hurst J., Grosveld F. Regulated expression of human A gamma-, beta-, and hybrid gamma beta-globin genes in transgenic mice: manipulation of the developmental expression patterns. Cell. 1986 Jul 4;46(1):89–94. doi: 10.1016/0092-8674(86)90862-7. [DOI] [PubMed] [Google Scholar]
  16. Krumlauf R., Hammer R. E., Brinster R., Chapman V. M., Tilghman S. M. Regulated expression of alpha-fetoprotein genes in transgenic mice. Cold Spring Harb Symp Quant Biol. 1985;50:371–378. doi: 10.1101/sqb.1985.050.01.047. [DOI] [PubMed] [Google Scholar]
  17. Lacy E., Roberts S., Evans E. P., Burtenshaw M. D., Costantini F. D. A foreign beta-globin gene in transgenic mice: integration at abnormal chromosomal positions and expression in inappropriate tissues. Cell. 1983 Sep;34(2):343–358. doi: 10.1016/0092-8674(83)90369-0. [DOI] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Lane D. P., Hoeffler W. K. SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature. 1980 Nov 13;288(5787):167–170. doi: 10.1038/288167a0. [DOI] [PubMed] [Google Scholar]
  20. Larsen P. R., Harney J. W., Moore D. D. Repression mediates cell-type-specific expression of the rat growth hormone gene. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8283–8287. doi: 10.1073/pnas.83.21.8283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Larsson L. I. Two distinct types of islet abnormalities associated with endocrine pancreatic tumours. Virchows Arch A Pathol Anat Histol. 1977 Nov 25;376(3):209–219. doi: 10.1007/BF00432397. [DOI] [PubMed] [Google Scholar]
  22. Leder A., Pattengale P. K., Kuo A., Stewart T. A., Leder P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell. 1986 May 23;45(4):485–495. doi: 10.1016/0092-8674(86)90280-1. [DOI] [PubMed] [Google Scholar]
  23. Lim A. T., Lolait S. J., Barlow J. W., Autelitano D. J., Toh B. H., Boublik J., Abraham J., Johnston C. I., Funder J. W. Immunoreactive arginine-vasopressin in Brattleboro rat ovary. Nature. 1984 Jul 5;310(5972):61–64. doi: 10.1038/310061a0. [DOI] [PubMed] [Google Scholar]
  24. Lolait S. J., Markwick A. J., McNally M., Abraham J., Smith A. I., Funder J. W. Anterior pituitary cells from Brattleboro (di/di), Long-Evans and Sprague-Dawley rats contain immunoreactive arginine vasopressin. Neuroendocrinology. 1986;43(5):577–583. doi: 10.1159/000124584. [DOI] [PubMed] [Google Scholar]
  25. Maxam A. M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560–564. doi: 10.1073/pnas.74.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Messing A., Chen H. Y., Palmiter R. D., Brinster R. L. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature. 1985 Aug 1;316(6027):461–463. doi: 10.1038/316461a0. [DOI] [PubMed] [Google Scholar]
  27. Mulligan R. C., Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2072–2076. doi: 10.1073/pnas.78.4.2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nussey S. S., Ang V. T., Jenkins J. S., Chowdrey H. S., Bisset G. W. Brattleboro rat adrenal contains vasopressin. Nature. 1984 Jul 5;310(5972):64–66. doi: 10.1038/310064a0. [DOI] [PubMed] [Google Scholar]
  29. Oberg K., Wälinder O., Boström H., Lundqvist G., Wide L. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I. Am J Med. 1982 Nov;73(5):619–630. doi: 10.1016/0002-9343(82)90401-6. [DOI] [PubMed] [Google Scholar]
  30. Ornitz D. M., Palmiter R. D., Messing A., Hammer R. E., Pinkert C. A., Brinster R. L. Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice. Cold Spring Harb Symp Quant Biol. 1985;50:399–409. doi: 10.1101/sqb.1985.050.01.050. [DOI] [PubMed] [Google Scholar]
  31. Palmiter R. D., Brinster R. L. Germ-line transformation of mice. Annu Rev Genet. 1986;20:465–499. doi: 10.1146/annurev.ge.20.120186.002341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Palmiter R. D., Brinster R. L., Hammer R. E., Trumbauer M. E., Rosenfeld M. G., Birnberg N. C., Evans R. M. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature. 1982 Dec 16;300(5893):611–615. doi: 10.1038/300611a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Palmiter R. D., Chen H. Y., Messing A., Brinster R. L. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 1985 Aug 1;316(6027):457–460. doi: 10.1038/316457a0. [DOI] [PubMed] [Google Scholar]
  34. Palmiter R. D., Norstedt G., Gelinas R. E., Hammer R. E., Brinster R. L. Metallothionein-human GH fusion genes stimulate growth of mice. Science. 1983 Nov 18;222(4625):809–814. doi: 10.1126/science.6356363. [DOI] [PubMed] [Google Scholar]
  35. Rigby P. W., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. doi: 10.1016/0022-2836(77)90052-3. [DOI] [PubMed] [Google Scholar]
  36. Rivier C., Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology. 1983 Sep;113(3):939–942. doi: 10.1210/endo-113-3-939. [DOI] [PubMed] [Google Scholar]
  37. Robertson G. L. The regulation of vasopressin function in health and disease. Recent Prog Horm Res. 1976;33:333–385. doi: 10.1016/b978-0-12-571133-3.50015-5. [DOI] [PubMed] [Google Scholar]
  38. Ruppert S., Scherer G., Schütz G. Recent gene conversion involving bovine vasopressin and oxytocin precursor genes suggested by nucleotide sequence. Nature. 1984 Apr 5;308(5959):554–557. doi: 10.1038/308554a0. [DOI] [PubMed] [Google Scholar]
  39. Sausville E., Carney D., Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem. 1985 Aug 25;260(18):10236–10241. [PubMed] [Google Scholar]
  40. Schimke R. N. Multiple endocrine neoplasia: search for the oncogenic trigger. N Engl J Med. 1986 May 15;314(20):1315–1316. doi: 10.1056/NEJM198605153142010. [DOI] [PubMed] [Google Scholar]
  41. Schmale H., Richter D. Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature. 1984 Apr 19;308(5961):705–709. doi: 10.1038/308705a0. [DOI] [PubMed] [Google Scholar]
  42. Small J. A., Blair D. G., Showalter S. D., Scangos G. A. Analysis of a transgenic mouse containing simian virus 40 and v-myc sequences. Mol Cell Biol. 1985 Apr;5(4):642–648. doi: 10.1128/mcb.5.4.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Small J. A., Khoury G., Jay G., Howley P. M., Scangos G. A. Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8288–8292. doi: 10.1073/pnas.83.21.8288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Small J. A., Scangos G. A., Cork L., Jay G., Khoury G. The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell. 1986 Jul 4;46(1):13–18. doi: 10.1016/0092-8674(86)90855-x. [DOI] [PubMed] [Google Scholar]
  45. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  46. Swanson L. W., Simmons D. M., Arriza J., Hammer R., Brinster R., Rosenfeld M. G., Evans R. M. Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. 1985 Sep 26-Oct 2Nature. 317(6035):363–366. doi: 10.1038/317363a0. [DOI] [PubMed] [Google Scholar]
  47. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Uhl G. R., Reppert S. M. Suprachiasmatic nucleus vasopressin messenger RNA: circadian variation in normal and Brattleboro rats. Science. 1986 Apr 18;232(4748):390–393. doi: 10.1126/science.3961487. [DOI] [PubMed] [Google Scholar]
  49. Vogelstein B., Gillespie D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci U S A. 1979 Feb;76(2):615–619. doi: 10.1073/pnas.76.2.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. WERMER P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954 Mar;16(3):363–371. doi: 10.1016/0002-9343(54)90353-8. [DOI] [PubMed] [Google Scholar]
  51. Wolfson B., Manning R. W., Davis L. G., Arentzen R., Baldino F., Jr Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature. 1985 May 2;315(6014):59–61. doi: 10.1038/315059a0. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES